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Abstract. During endochondral bone formation, hy-
pertrophic cartilage is replaced by bone or by a marrow
cavity. The matrix of hypertrophic cartilage contains at
least one tissue-specific component, type X collagen.
Structurally type X collagen contains both a collage-
nous domain and a COON-terminal non-collagenous
one. However, the function(s) of this molecule have
remained largely speculative. To examine the behavior
and functions of type X collagen within hypertrophic
cartilage, we (Chen, Q., E. Gibney, J. M . Fitch, C. Lin-
senmayer, T. M. Schmid, and T. F. Linsenmayer.
1990. Proc. Natl. Acad. Sci. USA. 87:8046-8050) re-
cently devised an in vitro system in which exogenous
type X collagen rapidly (15 min to several hours)
moves into non-hypertrophic cartilage. There the mole-
cule becomes associated with preexisting cartilage col-
lagen fibrils. In the present investigation, we find that
the isolated collagenous domain of type X collagen is
sufficient for its association with fibrils. Furthermore,
when non-hypertrophic cartilage is incubated for a
D
URING endochondral bone formation, hypertrophic
chondrocytes and their investing matrix are removed
and replaced by a marrow cavity and bony tissue.
Type X collagen, a hypertrophic cartilage-specific extracel-
lular matrix molecule, is thought to be involved in these
processes, but in what way remains unclear. Several possible
roles have been suggested, but at present none seems entirely
satisfactory. The molecule may facilitate matrix degrada-
tion. During development, soon aftertype X collagen is pro-
duced, the matrix into which it is deposited is degraded (9,
25). This may be related to the observation that in vitro, type
X is much more readily cleaved by vertebrate collagenase
than is type II collagen (29), the most prevalent type within
cartilage. The presence of type X collagen, however, does
not necessarily result in matrix removal; in mature organ-
isms, a thin seam ofpermanent type X-containing matrix re-
mains subjacent to the articular cartilages at the ends oflong
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longer time (overnight) with "intact" type X collagen,
the molecule is found both in the matrix and inside of
the chondrocytes. The properties of the matrix of such
type X collagen-infiltrated cartilage become altered .
Such changes include: (a) antigenic masking of type X
collagen by proteoglycans; (b) loss of the permissive-
ness for further infiltration by type X collagen; and (c)
enhanced accumulation of proteoglycans. Some of these
changes are dependent on the presence of the 000H-
terminal non-collagenous domain of the molecule. In
fact, the isolated collagenous domain of type X col-
lagen appears to exert an opposite effect on proteogly-
can accumulation, producing a net decrease in their
accumulation, particularly of the light form(s) of pro-
teoglycans. Certain of these matrix alterations are sim-
ilar to ones that have been observed to occur in vivo.
This suggests that within hypertrophic cartilage type X
collagen has regulatory as well as structural functions,
and that these functions are achieved specifically by its
two different domains.
bones. Another role proposed for the molecule is an involve-
ment in calcification. Here again, definitive experiments are
lacking, with some studies suggesting that the deposition of
type X correlates with the initiation of calcification (30),
whereas others have been interpreted as suggesting that it
produces a focal inhibition of calcification (20) .
The type X collagen molecule itself is about half the size
of a "typical fibril-forming collagen molecule (for review
see reference 26) . It is comprised largely of a 138-nm-long
triple helical collagenous domain, with a large globular do-
main at its COOH-terminal end. The globular domain has
certain characteristics reminiscent of the extensions found
on the procollagen, precursor forms ofsome collagens. Ifthe
globular domain served solely as a procollagen extension, it
would be removed soon after the molecule is secreted. Data
suggest, however, that it is the intact form oftype X collagen
which is found within hypertrophic cartilage matrix (27, 32).
Thus, the globular domain is likely to be functional.
Electron microscopic studies have suggested that the type
X molecule occurs in at least two different forms in hyper-
trophic cartilage matrix. One form appears as mats of
687filamentous material which surround the chondrocytes,
forming the innermost layer of the chondrocyte lacunae (28).
In the interstitial matrix, type X is observed associated with
the thin type II+IX+XI heterotypic collagen fibrils found
throughout hyaline cartilage matrix (20, 28) . This latter as-
sociation, we proposed (28), most likely represents an inter-
action of newly secreted type X collagen with preexisting
cartilage-collagen fibrils.
Such an interaction would require the movement of type
X molecules through the cartilage matrix. Recently, we (2)
tested the feasibility of this model by incubating the caudal,
non-hypertrophic portion of embryonic sternal cartilage
(which has no endogenous type X collagen) in medium con-
taining type X. We then used immunofluorescence and im-
munoelectron microscopy to evaluate the behavior of the
molecule. The results demonstrated that within minutes,
type X collagen molecules can pass into such cartilage ma-
trix; within 3 h the entire sternal piece can become infil-
trated. By that time much of the type X has become asso-
ciated with fibrils.
Using this same system, we now report that type X colla-
gen can, in addition, become internalized within chondro-
cytes. It can also alterthe properties ofthe matrix by regulat-
ing the accumulation of proteoglycans both quantitatively
and qualitatively. The triple-helical and globular domains of
the molecule seem to function differently in these processes.
Materials and Methods
Purification of Type X Collagen and Its
Collagenous Domain
Type X collagen was isolated from the medium of aged cell cultures of
hypertrophic tibiotarsal chick chondrocytes. The material was purified by
fractional salt separation as previously described (24), followed by affinity
purification (18) on columns of anti-type X mAb X-AC9 (25). For affinity
purification, the type X collagen (in 1 M NaCl, 50 mM Tris-HCI, 1% Triton
X-100, pH 7.5) was loaded onto a column of antibody X-AC9 coupled to
Sepharose CL-4B. The column was extensively washed and then the type
X collagen was eluted with 2 M guanidinium chloride. Such preparations,
as analyzed by SDS-PAGE, consisted solely of the intact form of type X
collagen. The triple helical, collagenous domain was produced by limited
pepsin cleavage of type X, followed by antibody affinity chromatography
on X-AC9 antibody columns.
In Vitro Culture of Cartilage
Sterna were removed from embryonic chicks (12 d of incubation) and dis-
sected into HBSS. The perichondrium was stripped off and pieces from the
caudal 1/2-1/3 ofthe sternum (the "permanent" cartilaginous region which
does not synthesize type X collagen) were used.
For the experimental incubations, the medium consisted of DME sup-
plemented with or without 10% FCS and exogenous collagen. The concen-
tration oftype X collagen or ofthe triple helical collagenous domain of type
X collagen routinely used was 60 ug/ml . Sternal pieces (three as a group)
were added to the medium in 24-well tissue culture plates (Costar, Cam-
bridge, MA). The plates were then incubated for various times at 37°C on
a Nutator rocking table to ensure gentle mixing.
Standardization ofSternal Pieces
For experiments in which quantitation of radiolabeled material was deter-
mined (described below) groups ofeither three or four size-matched sternal
pieces were used for each determination. To evaluate the precision with
which size matching could be performed, the wet weights of 24 such sternal
pieces were determined with an electrobalance (model 4400; Cahn Instru-
ments, Inc., Cerritos, CA) . The pieces had a mean weight of 4.48 mg with
a SD of0.38mgor8.5%.
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Immunofluorescence Histochemistry
After culturing, the sternal pieces were quickly rinsed in PBS and fixed in
4% paraformaldehyde for 20 min. Further processing for cryostat section-
ing and for the indirect immunofluorescence procedure with anti-collagen
mAbs were as previously described (7).
Before reaction with antibody, some sections were digested with either
5 mg/ml testicular hyaluronidase or 5 U/ml chondroitinase ABC (Sigma
Chemical Co., St. Louis, MO) in PBS for 30 min at 37°C.
Immunoelectron Microscopy
Immunoelectron microscopy using ultrathin cryostat sections was per-
formed as recently described (8). Briefly, the incubated pieces of cartilage
were fixed in paraformaldehyde-lysine-periodate fixative, infiltrated with
sucrose at 4°C, mounted on stubs and frozen. 100-nm sections were cut with
an ultracryotome (FC4; Reichert Jung, Vienna, Austria), placed on
formvar-coated grids and reacted with antibodies complexed to colloidal
gold particles. Sections were viewed in an electron microscope (CM10;
Philips Electronic Instruments, Inc., Mahwah, NJ). Stereo pairs were pho-
tographed at an angle of 40°.
Radioisotopic Analysis ofType X Collagen Movement
Radiolabeled type X collagen was purified from hypertrophic chondrocytes
incubated in the presence of [3Hlproline. For experimental incubations,
2,000 dpm of radiolabeled type X was added along with 60 jug/ml of the
unlabeled molecule. Then, at various time points, labeled sternal pieces
(size-matched) were removed from the incubation medium, and the labeled
tissues were quickly rinsed to remove surface-associated isotope. The ster-
nal pieces were solubilized in a tissue solubilizer-450 (Beckman Instru-
ments, Inc.) and counted in Ready Organic Liquid Scintillation Cocktail
(Beckman Instruments, Inc.).
Proteoglycan Radiolabeling andAnalysis
Size-matched sternal cartilage pieces were incubated for 15 h at 37°C in
medium containing 50 ACi/ml HZ35SO4 (New England Nuclear, Boston,
MA). Test cultures also contained either intact type X collagen or the
pepsin-resistant collagenous domain of the molecule (60 ug/ml). After cul-
ture, the radiolabeled proteoglycans were extracted (21). Tissues and
medium were processed separately. The labeled cartilage pieces were
washed three times in PBS and homogenized at 4°C in extraction buffer
(4 M guanidine HCI, 50 mM sodium acetate, pH 5.8, 5 mM N-ethylmalei-
mide, 0.5 mM disodium ethylenediaminetetraacetate, and 0.5 mM PMSF).
After overnight extraction, the extracts and media were separately dialyzed
against Tris/HCl (pH 6.8) and 1 mM sodium sulfate. The radioactivity in
an equal portion of each sample was determined.
The distribution ofthe different classes ofproteoglycans in each sample
was analyzed by agarose gel electrophoresis (19). Equal portions (10%) of
each sample were heated in the presence of0.25% SDS at 37°C for 2 h and
then subjected to electrophoresis through a 1% agarose gel .
Results
Association of the Collogenous Domain of Type X
Collagen with Cartilage Collagen Fibrils
Pieces of non-hypertrophic sternal cartilage from 12-d em-
bryoswere incubated in either control medium (Fig. 1, A and
D), medium containing intact type X collagen (Fig. 1, B and
E), or medium containing the collagenous domain of type
X from which the COOH-globular domain had been re-
moved by limited pepsin digestion (Fig: 1, C and F). The
cartilages were then assayed by immunofluorescence histo-
chemistry and immunoelectron microscopy. Consistent with
our previous results (2), both the type X collagen and its iso-
lated collagenous domain completely penetrated the carti-
lage within 3 h, as assayed by immunofluorescence histo-
chemistry. Therefore, the ability of the molecule to move
through cartilage lies within the collagenous domain.
688Figure 1. (A-C) Fluorescence micrographs of sections of sterna incubated for 3 h in control medium (A), medium containing typeX collagen
(B), or medium containing the collagenous domain of type X collagen (C) . Sections were reacted with the monoclonal antibody for type
X collagen and then with a rhodamine-conjugated secondary antibody. (D-F) Double-label immunoelectron micrographs ofsternal carti-
lage that had been incubated for 3 h in medium containing type X collagen (D and E), or the collagenous domain of type X collagen
(F) . As a negative control, D was reacted with an anti-laminin mAb coupled to 15-nm gold and an anti-type IV collagen mAb coupled
to 5-nm gold . EandFwere reacted with the anti-type X collagen mAb coupled to 15-nm colloidal gold and an anti-type II collagenmAb
coupled to 5-nm gold . Bars : (A-C) 100 ,m ; (D-F) 100 nm .
When we examined the incubated cartilages by immuno-
electron microscopy, again, aswe previously reported, much
of the intact type X collagen (Fig . 1 E, large gold particles)
had become associated with the cartilage collagen fibrils,
identifiable by the presence of type II collagen (small gold
particles) . In addition, we observed that the pepsin-derived
collagenous domain of the molecule became associated with
fibrils in a distribution indistinguishable from that of the in-
tact molecule (Fig . 1 F) . Thus, the information for type X
tobecome associated with fibrils also resides within the col-
lagenous domain .
TypeXCollagen-mediatedAlterations
ofCartilageMatrix
When the incubation period for the sternal pieces was ex-
tended to overnight (15 h ; Fig . 2), a difference was noted be-
tween sterna incubated with the intact type X molecule
versus sterna incubated with the collagenous domain oftype
X . In sterna that had been incubated with the intact molecule
(Fig. 2 A), the immunofluorescence for the typeX molecule
was substantially less than that seen at three hours (compare
with Fig . 1 B) . Throughout most of the sterna the fluores-
cence had decreased by 15 h to the point of being almost
nonexistent, the exception being near the surface, where a
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strong signal was still visible . In contrast, sterna incubated
overnight with the isolated collagenous domain (Fig . 2 B)
still retained much of the anti-type X fluorescence observed
at 3 h of incubation (compare with Fig . 1 C) .
We previously observed that the movement of type X col-
lagen into cartilage does not require active cellular metabo-
lism (2), since it occurs at 4°C and in sterna in which the
cells have been killed by freeze-thawing. The diminution of
the type X immunofluorescence during the overnight incuba-
tion, however, does seem to require active metabolism and
also cellular secretion . Neither freeze-thawed sterna in-
cubated overnight in type X-containing medium at 37°C nor
living sterna incubated overnight in type X-containing
medium at 4°C (Fig. 2 C) exhibit a decrease in the type X
collagen immunofluorescence. Likewise, sterna incubated
overnight in medium containing both type X collagen and
monensin, an inhibitor of cellular secretion, show no de-
creased fluorescence signal (Fig . 2 D) .
Another alteration in the sterna which occurred during the
overnight incubation in intact type X collagen-containing
medium was that the matrix could no longer be infiltrated by
typeX . When sterna were incubated overnight in typeX and
then transferred the next day to fresh type X-containing me-
dium for an additional 3-h incubation, we observed little if
any increase in the fluorescent signal for type X (Fig . 2 E) .
689This alteration in the cartilage matrix had been effected by
the infiltrated type X collagen . Control sterna that had been
incubated overnight inmediumwithout typeX and then trans-
ferred the next day to medium containing type X exhibited
the normal inward movement of the molecule (not shown) .
These observations were confirmed by similar experiments
in whichwe assessed the ability of radiolabeled type X colla-
gen to move into sterna which had been incubated overnight
in medium with or without exogenous unlabeled type X .
When such sterna were transferred the next day to medium
containing 3H-labeled type X, those which had been in-
cubated in controlmedium showed appreciable uptake of the
radiolabeled collagen (Fig . 3, ) ; those which had been
incubated in type X collagen-containing medium showed
only slight uptake (Fig . 3, ----) .
Alterations in Matrix Proteoglycans
One possibility that would account for all of these observa-
tions would be the addition to the matrix of a chondrocyte-
secreted component(s) that could antigenically maskepitopes
on the type X collagen molecule and alter other properties
of the matrix . Numerous studies have demonstrated that car-
tilage matrix proteoglycans can antigenically mask epitopes
on collagens . To test whether this might be occurring in the
sterna incubated overnight in type X collagen, sections of
this tissue were predigested with either testicular hyaluroni-
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Figure 2 . Fluorescence micrographs of
sections of sterna incubated for 15 h at
37°C in medium containing intact type X
collagen (A) ; the collagenous domain of
type X collagen (B) ; at 4°C in medium
containing intact type X (C) ; at 37°C in
medium containing monensin and intact
type X collagen (D) ; in intact type X con-
taining medium for 15 h followed by an
additional 3-h incubation in fresh type
X-containing medium (E) . None of these
sections had been digested with hyaluroni-
dase . F is the same as A but digested with
hyaluronidase before reaction with anti-
body . Sections were reacted with themAb
fortype X collagen and then with a rhoda-
mine-conjugated secondary antibody. Bar,
100 Wm .
dase or chondroitinase ABC before reaction with the anti-
type X antibody. Both treatments greatly increased the type
X immunofluorescence (Fig . 2 F) .
These results suggest that proteoglycan was interacting
with the typeX collagen, and that the COOH-terminal globu-
lar domain of the molecule is involved . The inhibition of
masking by monensin suggests that it is the PG newly synthe-
sized during the incubation period that interacts with type X
collagen .
To test whetherthe exogenous typeX was regulating the ac-
cumulation of newly synthesized proteoglycan(s) and to de-
termine which domain of the molecule might be responsible
for such activity, we examined the amounts and types ofnewly
synthesized proteoglycans that accumulated within cultured
sterna infused overnight with either intacttypeX or its collag-
enous domain . Synthesis was tested both in serum-containing
medium, which produced an intrinsically high synthetic rate
of the proteoglycans, and in serum-free medium, which sup-
ported a basal level of synthesis .
[11S]sulfate incorporation into nondialyzable, macromo-
lecular material was examined as an indicator oftotal proteo-
glycan accumulation since in cartilage -95% of the sulfate
is incorporated into proteoglycans (15, 16) . Both the tissue-
associated, 4 M guanidine-extractable fraction and the me-
dium fraction were examined ; under all experimental condi-
tions, the great majority of the label was within the tissue
fraction (Fig . 4) . Only this fraction will be described . In
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Figure3 . Uptake of 3H-labeled typeX collagen by a group of three
sternal pieces that had been incubated for 15 h in type X-containing
medium (- - - -) or in control medium (
￿
) .
serum-free medium the intact typeX molecule produced an
80% increase in [35S]sulfate incorporation as compared to
the control level (Fig . 4) . In serum-containing medium, in
which the basal incorporation was much greater, this incre-
ment was 20% .
When the collagenous domain of type X was tested, the
results weremuch different . In serum-free medium the amount
of labeled sulfate was almost identical to that of the control ;
in serum-containing medium it was 26% less than that of the
control .
Cartilage contains at least two types of proteoglycans, a
large one (designated PG-H), a small one (designated PG-L)
(31), as well as type IX collagen, a collagen/proteoglycan .
To determine which of these sulfate-containing macro-
molecules was being affected by type X collagen and its col-
lagenous domain, we subjected equal proportions (10%) of
each of the [35S]sulfate-containing fractions to agarose gel
electrophoreses, previously shown to separate these compo-
nents (19) . The serum-containing cultures were examined
since these showed an increase with the intact type X and a
decrease with the collagenous domain .
The data are shown in Fig . 5 . In control cultures (lane A),
Figure 4 . [35S]sulfate accumulation by sternal pieces after 15-h in-
cubation in [35S]sulfate-containing control media (®) or media
containing 60 14g/ml type X collagen (m) or with 60 tcg/ml of the
collagenous domain of type X collagen (®) . Both serum-contain-
ing (serum)and serum-free (free) media were tested, as were tissue
and medium fractions of each . All samples have been normalized
to the samples in serum-containing control medium (designated as
100%) . The vertical bars show 1 SD.
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Figure S . Autoradiogram of [ 35S]sulfate-labeled macromolecules
separated in a 1% agarose gel (typical representative of three sepa-
rate experiments) . (Lanes A- C) Tissue extracts of sterna incubated
in control medium (A), or in medium containing 60 lAg/ml of the
collagenous domain of typeX (B), or 60 hg/ml intact typeX (C) .
(Lanes H-J) Tissue extracts (A-C), respectively, digested with
hyaluronidase. (Lanes D-F) Media fractions in which sterna were
incubated the same as A-C respectively. (Lane G) Tissue extract
(C) reduced with 0-mercaptoethanol .
two bands are present, one corresponding to PG-H and the
other to PG-L . When intact type X collagen was included
in the cultures (lane C), the net increase in
355 incorpora-
tion noted earlier was found to be due to PG-H, whereas
PG-L was actually decreased . The net decrease in
35S in-
corporation observed when the collagenous domain of type
X was included in the cultures was found to be due to de-
creases in both proteoglycan species, with the PG-L being
almost completely eliminated (laneB) . As expected, the me-
dium fractions of the cultures (lanes D-F) contained little
material . Hyaluronidase treatment of cultures (lanes D-F)
contained little material . Hyaluronidase treatment of lanes
A-C eliminated the labeled materials (lanes H-J), consistent
with the great majority of the 35S label being incorporated
into proteoglycan . Reduction with ß-mercaptoethanol(lane
G) did not alter the migration of either labeled component,
suggesting that neither labeled component was type IX col-
lagen, the mobility of which is increased upon reduction
(1, 19) .
Chondrocyte Internalization of TypeX
These results suggest that the domains of type X collagen
differentially affect proteoglycan accumulation . How this oc-
curs is not yet known, but an additional observation may be
related to this phenomenon . During the overnight incuba-
tion, some of the exogenously added intact type X collagen
is internalized by the chondrocytes . This has been demon-
strated by both immunofluorescence histochemistry (Fig . 6,
insert) and immunoelectron microscopy (Fig. 6) . In the im-
munofluorescence insert, to emphasize the punctate intracel-
lular pattern of antibody reaction for type X collagen (ar-
rows), the tissue section was not treated by hyaluronidase, so
69 1Figure 6. Immunoelectron micrograph of a chondrocyte and surrounding area from a sternal piece that had been incubated in type X-con-
taining medium for 15 h . The section was digested with hyaluronidase and reacted with an anti-type X collagenmAb 15-nm gold complex .
The small arrows designate type X collagen associated with the cell surface ; the large arrows type X collagen-containing intracellular
vacuoles. N, nucleus ; M, cartilage matrix . (Inset) Fluorescence micrograph of a section of sternum that had been incubated in type X
collagen-containing medium for 15 h . Section is reacted with anti-type X collagen mAb, but without hyaluronidase treatment . (White ar-
rows, intracellular inclusions of type X collagen), Bars : 225 nm ; (Inset) 4.5 jm .
the matrix-associated type X has remained largely masked
by proteoglycan .
Immunoelectron microscopy of ultrathin cryostat sections
showed that some typeX was closely associated with the cell
surface and some was within what appear to be intracellular
vacuoles (arrows) . That this typeX is truly intracellular was
verified by visualizing sections in stereo pairs (not shown) .
Few ofsuch internalization was observed in sterna incubated
with the isolated collagenous domain of typeX (but see Dis-
cussion) . To demonstrate that the intracellular type X was
truly endocytosed, and was not a result of de novo synthesis
by these sternal chondrocytes, we looked for type X collagen
mRNAby in situ hybridization (17) . In the in vitro-incubated
cartilages no mRNA for type X collagen was detected ; in
control hypertrophy cartilage taken directly from embryos,
an intense signal for the mRNA was observed (data not
shown) .
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Discussion
Using the same in vitro model system employed here, we
previously reported a rapid and extensive movement of type
X collagen through cartilage matrix . We also observed that
the triple helical domain ofthe molecule is sufficient for this
movement . In vivo it is unnecessary and unlikely that the ex-
tent ofmovement oftypeX molecules approaches that which
we observe in this in vitro model system (discussed later) .
This model does, however, seem to mimic and offer explana-
tions for a number of changes that occur during cartilage
hypertrophy in vivo, thus facilitating studies of the mecha-
nisms involved.
Using this system, we (2) previously observed that the
fibril-associated form of type X collagen seen within hyper-
trophic cartilage in vivo (20,28) could result from the associ-
ation oftypeXwith preexisting cartilage collagen fibrils . We
havenow observed other type X-mediated modifications, in-
692cluding alterations in the accumulation of proteoglycans, al-
terations in the physical properties of the cartilage matrix
with respect to type X collagen movement, and uptake ofthe
molecule by the chondrocytes. Certain ofthese changes mir-
ror the events that occur in vivo during the formation of
hypertrophic matrix, and they appear to be regulated by the
different domains of the type X molecule.
FibrilAssociation
Wepreviously observed that the movement oftype X through
the matrix is a property conferred upon the molecule by its
triple helical domain. As shown in the present study, this do-
main also seems to be sufficient for association of the mole-
cule with the type II+IX+XI collagen fibrils already present
within the matrix. This result is consistent with the proposal
(28) that within hypertrophic cartilage in vivo, one of the
fatesof the newly synthesized type X is to become associated
with preexisting fibrils assembled at an earlier stage of carti-
lage development. This association may alter such properties
of the fibrils as their susceptibility to degradation, their abil-
ity to participate in calcification, and their interactions with
proteoglycans (discussed later) .
At least one fibril-associated collagen, type IX, is known
to align along fibrils in such a way that it is in register with
the underlying type II collagen molecules comprising most
of the fibril. It is likely that type X collagen becomes simi-
larly arranged. Some evidence exists that type X molecules
become covalently bound to fibrils via lysine-derived cross-
linking (3, 22, 24), and the formation of such crosslinks re-
quires specific alignment ofthe molecules involved . Possibly
the other fibril-associated collagens, such as the types IX
(33), XII (5, 10, 14), and XIV (6, 14), can move through their
respective matrices. If so, modification of preexisting fibrils
by the addition of newly synthesized fibril-associated colla-
gens may prove to be a common mechanism by which the
properties of such fibrils become altered during devel-
opment.
Alterations in Matrix Proteoglycans
Another response ofcartilage to the presence oftype X colla-
gen is an alteration in the matrix proteoglycans, resulting in
both antigenic masking of the type X molecules within the
matrix and changes in the proteoglycans. These alterations
require de novo cellular synthesis and secretion, and differ
depending on which domain(s) of type X collagen are
present.
The most dramatic proteoglycan-mediated change in the
immunohistochemistry of the matrix is the antigenic mask-
ing of the type X collagen itself. This is most obvious when
the intact type X molecule is tested, implicating the 000H-
terminal globular domain in one or more of the processes
that may be responsible for the masking.
One way in which the COOH-terminal domain may act is
by promoting the binding of newly synthesized proteogly-
can(s) to the type X collagen molecule. Although the epitope
against which our anti-type X collagen antibody is directed
is within the triple helical domain, it is located only 19 nm
from the COOH-terminal domain (29), a distance easily
spanned by individual PG-H monomers (11, 23), let alone
the supramolecular PG-H aggregate form of the molecule
which is many times larger. More work, however, will be re-
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quired to determine precisely the interactions between type
X collagen and proteoglycan, and to elucidate the involve-
ment of the COOH-terminal domain .
Our data do, however, directly demonstrate a differential
effect oftype X collagen and its COOH-terminal domain on
the accumulation of newly synthesized proteoglycans within
the matrix. The intact type X molecule produced a net in-
crease in proteoglycan accumulation, due to increased PG-H.
Pg-L was actually decreased. In contrast, the isolated col-
lagenous domain produced a decrease in both proteoglycan
species, with the PG-L being almost completely absent.
Thus, it seems that the COOH-terminal domain enhances the
accumulation of PG-H, whereas the collagenous domain in-
hibits the accumulation of PG-L.
We do not yet know whether these net effects on proteogly-
chn accumulation involve changes in synthesis, which would
indicate an involvement of cellular receptors (discussed be-
low), changes in degradation, or a combination of the two.
The changes do, however, seem to mimic certain ones ob-
served during the formation of hypertrophic cartilage in
vivo, and they may produce physiological differences within
the growth plate.
One such correlation is the distribution of the light form
proteoglycan in the epiphyseal growth region. Shinomura et
al. (31) using immunohistochemistry with antibodies specific
for the different forms of proteoglycan, observed that one
light form of proteoglycans, PG-Lb, distributed throughout
the cartilage of the epiphyseal growth region except for the
hypertrophic zone. PG-H, however, was present throughout
both nonhypertrophic and hypertrophic cartilage. This ab-
sence of PG-Lb as well as the continuing presence of PG-H
in the hypertrophic cartilage are consistent with the regula-
tory effects we observed for type X collagen and its collage-
nous domain . In vivo, however, it is unlikely that the entire
collagenous domain (45413 form) of type X molecule acts
in regulation, since it is unlikely that this form of the mole-
cule is present within cartilage matrix (27, 32) . More likely,
the activity resides in a collagenous cleavage product of the
molecule. We (29) previously observed that the type X mole-
cule is readily cleaved by vertebrate collagenase, an enzyme
found within the hypertrophic zone of the growth plate (4).
The major product of this cleavage is a triple helical frag-
ment comprising approximately three-quarters of the colla-
genous domain ofthe molecule. This fragment can be excised
en bloc from the central portion of the molecule and has
sufficientthermal stability to maintain the triple helical con-
formation. It could perform in vivo as the collagenous do-
main does in vitro.
Alterations in Type X Movement into the Matrix
After exposure to the intact type X molecule, the sternal car-
tilage matrix no longer allows further infiltration ofthe mole-
cule. This suggests a dramatic decrease, or even a cessation,
of type X movement within the matrix. We do not yet know
if this alteration in the physical properties of the matrix is
related to the concomitant increase observed in the proteo-
glycan content ofthe matrix, but it does provide an explana-
tion for the restricted localization of type X to the hyper-
trophic matrix. In vivo, ifthe de novo secreted type X effects
a rapid change in the physical properties of the matrix sur-
rounding individual chondrocytes, the extent ofmovement of
the molecule would be much more limited than is observed
693in our in vitro model in which a large amount of type X is
rapidly made available to the tissue. This could explain why,
in vivo, type X remains localized within the hypertrophic
zone of the growth plate.
Internalizationof Type X by Chondrocytes
We observed that some ofthe exogenous intact type X colla-
gen becomes internalized by the chondrocytes. Whether this
uptake is mediated by a specific receptor remains to be
tested; however, one observation suggests that this may be
the case. By immunoelectron microscopy, we observed in-
ternalization of the intact type X molecule, but few if any of
the isolated collagenous domain. Although this suggests a
specific involvement ofthe globular domain, negative results
such as this must be interpreted with caution.
Internalization of the type X collagen may be required for
the regulation ofproteoglycan. Ifso, the apparent differences
in internalization observed between the intact type X mole-
cule and its collagenous domain might reflect the different re-
sponses these domains elicit in the behavior of proteogly-
cans. In addition, the internalization may indicate a feedback
mechanism responsible for regulating the synthesis of the
type X collagen itself (12, 13), or it may simply indicate a
method of degrading excess type X. Which, if any, of these
possibilities is correct, remains to be tested.
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